File(s) stored somewhere else
Please note: Linked content is NOT stored on Monash University and we can't guarantee its availability, quality, security or accept any liability.
Promoting physiological hypertrophy in the failing heart
Version 3 2022-07-21, 05:40
Version 2 2016-11-03, 01:01
Version 1 2016-11-03, 00:49
journal contribution
posted on 2016-11-03, 01:01 authored by Lynette PretoriusLynette Pretorius, Kate Owen, Gary Jennings, Julie McMullenHeart failure rates have reached epidemic proportions in Western society. New strategies proposed to improve cardiac function of the failing heart include regeneration, stem cell therapy, innovative methods for the revascularization of ischaemic cardiac tissue and the activation of signalling pathways that promote physiological growth (hypertrophy). The insulin-like growth factor 1-phosphoinositide–3-kinase pathway is a well characterized regulator of physiological hypertrophy. In this mini-review we present studies that suggest promoting physiological hypertrophy in the failing heart may be beneficial.